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conductivity. As in COPD patients, the pH was significantly 
decreased in chronic smokers with a history of at least 10 
pack-years compared to controls.  Conclusions: EBC can be 
used to detect the acute and chronic effects of smoking. The 
increased conductivity of EBC after smoking suggests acute 
inflammatory effects. The reduced pH in chronic smokers 
shows cigarette-induced inflammation. 
 Copyright © 2009 S. Karger AG, Basel 
 Background 
 Long-term tobacco smoking constitutes a major risk 
factor for chronic obstructive pulmonary disease (COPD), 
inducing inflammatory cell recruitment and activation 
as demonstrated by a variety of invasive and noninvasive 
techniques. In addition to long-term alterations, short-
term, acute responses to smoking could also provide in-
sight into the response of the respiratory tract. The non-
invasive techniques now available for analyzing airway 
inflammation are quite attractive and are increasingly 
used clinically.
 Such techniques include sputum induction, the assess-
ment of exhaled nitric oxide (FE NO ) and exhaled breath 
condensate (EBC). FE NO is a useful marker, especially in 
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 Abstract 
 Background: Long-term cigarette smoking is associated 
with pulmonary inflammation, but the acute effects of smok-
ing have been less well studied. Analysis of the exhaled 
breath condensate (EBC) can provide noninvasive markers 
that might be indicative of inflammation.  Objectives: The 
aim of the study was to determine whether the pH , electrical 
conductivity and the levels of ammonium and interleukin 8 
(IL-8) of EBC were altered in smokers and whether they 
changed after smoking a single cigarette.  Methods: We in-
cluded 19 healthy nonsmokers (controls), 29 asymptomatic 
smokers, 10 patients with stable chronic obstructive pulmo-
nary disease (COPD) [Global Initiative   for Chronic Obstruc-
tive Lung Disease stages (GOLD) stages II–III], and 10 patients 
with exacerbated COPD. In 13 smokers, EBC was also ana-
lyzed before and after smoking. EBC was obtained during 10 
min tidal breathing with a cooled RTube TM . pH was deter-
mined after deaeration with argon.  Results: Acute smoking 
did not alter the pH or ammonium and IL-8 levels, but raised 
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asthma, but its interpretation is difficult in smokers  [1] . 
Sputum induction yields information on inflammatory 
cells and mediators  [2, 3] but has methodological limita-
tions as well:  the procedure itself affects the airways and 
elicits both a neutrophilic response  [4] and a decrease in 
EBC pH  [5] .
 A low pH in EBC is assumed to reflect airway inflam-
mation as reported for several disorders: asthma  [6] , 
COPD  [7] , cystic fibrosis  [8] , lung transplant rejection  [9] , 
bronchiectasis  [10] . pH is of great interest for clinical ap-
plications as it can be measured shortly after EBC collec-
tion using simple equipment. The same applies to electri-
cal conductivity, which has been proposed as a correlate 
of the aerosol fraction of EBC, and which might also be a 
marker of airway inflammation  [11] .
 The analysis of EBC has revealed chronic inflamma-
tory alterations in smokers as compared to nonsmokers 
such as increased levels of interleukin (IL)-6 and IL-8 and 
leukotriene B 4  [12, 13] . Only few studies have focused on 
the acute effects of smoking, and only a small number of 
investigators used EBC to analyze local inflammatory re-
actions  [14–16] . Smoking can elicit acute effects even in 
smokers as demonstrated, for example, by a raised IL-8 
release from stimulated leukocytes  [17] . The aim of the 
present study was to investigate whether smoking exerts 
an acute effect on pH in smokers and whether the pH of 
the EBC of asymptomatic smokers, as a marker of in-
flammation, differs from that of nonsmokers. For com-
parison, we included patients with COPD. Along with the 
pH we also assessed electrical conductivity, ammonium 
and IL-8 in EBC samples from participants.
 Participants and Methods 
 Study Participants 
 The study population consisted of 29 asymptomatic smokers 
(16 males/13 females aged 38  8 12 years) with a smoking history 
of 21.9  8 18.5 pack-years (PYs); 20 subjects reported  1 10 PYs (26.8 
 8 17.4 PYs) and 9 subjects  ! 10 PYs (3.2  8 2.6 PYs). As control 
group, we enrolled 19 healthy nonsmokers (10 males/9 females 
aged 32  8 10 years) without a history of pulmonary disease. Two 
out of the healthy nonsmokers were ex-smokers with 5 PYs. Air-
way obstruction was ruled out by spirometry in both healthy non-
smokers and asymptomatic smokers ( table 1 ).
 For comparison, we included patients with stable COPD 
[Global Initiative   for Chronic Obstructive Lung Disease stages 
(GOLD) stages II–III] as defined by GOLD criteria, with no signs 
of exacerbation (9 males/1 female  aged 67.9  8 8.1 years). No pa-
tients had received treatment with oral steroids for at least 4 weeks 
before the measurements. Five were current smokers and 5 were 
ex-smokers. As a group with acute inflammation, we enrolled 10 
patients with COPD exacerbation (8 males/2 females aged 69.4  8 
11.6 years) defined by standard criteria  [18] . At the time of mea-
surement, they had not received any systemic corticosteroids. The 
study was approved by the local Ethics Committee and informed 
consent was obtained from each subject.
 All participants answered a questionnaire regarding symp-
toms, smoking habits, health status, medication and medical his-
tory. Moreover, blood samples were taken and differential cell 
counts performed. Systemic inflammation was ruled out in con-
trol subjects and smokers by low leukocyte counts and low serum 
levels of C-reactive protein and procalcitonin. Spirometry, follow-
ing American Thoracic Society/European Respiratory Society 
guidelines  [20] , was used to exclude airway obstruction in healthy 
controls and smokers, and to assess the stage of COPD according 
to GOLD criteria  [21] . Spirometry was not performed in the pa-
tients admitted due to an acute exacerbation.
 Study Design 
 In this observational study, EBC was collected at least once in 
all subjects and 3 times in the subgroup of smokers who were test-
ed before and after smoking a cigarette. The smokers refrained 
from smoking at least 2 h prior to measurements. In a random sub-
group of 13 asymptomatic smokers, the acute effect of smoking was 
assessed after smoking a single cigarette of a commercial brand 
(Gauloises Red) over a time period of 5–10 min. EBC was collected 
5–15 min after the end of smoking, as well as 15–25 and 25–35 min 
after the end of smoking. All samples were analyzed for pH.
 In addition to pH, electrical conductivity, IL-8 and ammoni-
um levels were determined in the EBC samples from 10 healthy 
control subjects and 10 smokers. In the smokers, in addition to 
pH, the EBC collected 5–15 min after smoking a single cigarette 
was used for these analyses. Limitations in the amount of avail-
able EBC prevented us from performing the additional measure-
ments in all subjects and at all time points.
Table 1. Patients’ characteristics
Male Female FEV1, % predicted FEV1/VC, % predicted Current smoking Age, years
Healthy controls 16 13 105.2811.1 98.889.1 (n = 0) 32.189.5
COPD 9 1 56.4813.5 64.6818.2 (n = 3) PYs: 31.1816.2 67.988.1
Exacerbated COPD 8 2 34.4811.4 54.7811.3 (n = 1) PYs: 47.4828.9 69.4811.6
Smokers 10 9 99.7810.6 98.187.9 (n = 29) PYs: 21.9818.5 38.2812.2
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 Methods 
 EBC Collection 
 EBC samples were collected during 10 min of quiet breathing 
through a single-use disposable RTube TM collector (Respiratory 
Research, Inc., Charlottesville, Va., USA), while subjects were 
wearing a nose clip. The aluminum sleeve of the device had been 
cooled to an initial temperature of –20 ° C prior to collection. After 
collection, the plunger was used to pool the condensed material 
within the tube into a single sample (about 1.0 ml). Samples were 
stored for a maximum of 4 weeks in reaction tubes at a tempera-
ture of –20 ° C before IL-8, conductivity and ammonium were 
measured. pH measurements were performed directly after  EBC 
sampling.
 Assessment of pH 
 For pH determination, 250   l of EBC were transferred into a 
polyethylene tube that had been washed with double-deionized 
water. Samples were de-aerated with a gentle argon flow (Linde 
Gas, Germany, purity 99.9%) for  6 20 min until pH readings were 
stable. pH was determined with a microelectrode and a pH meter 
(Windaus R , Clausthal-Zellersfeld, Germany), which were cali-
brated before each sequence of measurements, using pH values of 
4, 7 and 9. Samples used for pH determinations were not utilized 
for other measurements. pH measurements were performed di-
rectly after EBC sampling.
 Electrical Conductivity 
 Conductivity measurements were performed in 100   l EBC 
using a glass microcell (LDM/S; WTW, Weilheim, Germany) at a 
temperature of 25 ° C. The microcell was flushed with deionized 
water and dried with argon. All measurements were done in du-
plicate. Readings were always stable within few seconds, far above 
the detection limit of the device, and reproducible within  ! 2%.
 Ammonium 
 Ammonium measurements relied on the classical Berthelot 
reaction involving phenol, sodium hypochlorite, and sodium 
pentacyanonitrosylferrat (III). After incubation (pH 11.8–12.4, 
50 ° C, 1 h), the amount of NH 4 + ions in 50-  l samples of EBC was 
determined photometrically at 620 nm (UV-1602; Shimadzu, 
Duis burg, Germany). Four standards and 1 blank value treated in 
the same way as the samples were used to obtain the final concen-
trations. The limit of detection was 5 ng NH 4 + in 50   l, and the 
standard deviation of repeated measurements was about 2.5%.
 Interleukin 8 
 The level of IL-8 in EBC was determined by ELISA in dupli-
cate – using two 100-  l samples  without preconcentration – and 
an ultrasensitive IL-8 assay (Ultra Sensitive Kit, Biosource, Ni-
velles, Belgium). Measurements in blinded samples were performed 
by FILT GmbH, Berlin, Germany. The limit of detection was  ! 100 
fg/ml. The standard curve was fitted between 0 and 25 pg/ml.
 Analysis 
 Depending on the distribution of each variable, mean values 
and standard deviations (SD) or median values and interquartile 
ranges (IQR) were computed for data description. The different 
groups of control subjects were compared using the nonparamet-
ric Kruskal-Wallis analysis of variance (ANOVA). For (post hoc) 
comparisons between specific groups, the Mann-Whiney U test 
was employed. Friedman’s nonparametric ANOVA served to 
evaluate the time course of pH after smoking, and the Wilcoxon 
matched-pairs signed-ranks test was used to compare specific 
time points. Spearman’s rank correlation coefficients (r S ) were 
computed to quantify the degree of association between variables. 
No correction for the multiplicity of tests was performed, but p 
values are given explicitly wherever reasonable. Statistical signif-
icance was assumed at 5%.
 Results 
 Acute Effects of Smoking on EBC 
 EBC was collected from 13 current smokers at differ-
ent time points before and after smoking. Median (IQR 
in parentheses) pH before smoking (baseline) was 7.18 
(2.12), and 5–15, 15–25 and 25–35 min after smoking it 
was 7.41 (1.39), 7.58 (1.21), and 7.78 (0.59), respectively. 
Despite a tendency for some subjects to show an increased 
pH ( fig. 1 a), these 4 measurements were not statistically 
significantly different from each other (p = 0.392, Fried-
man).
 There was also no significant (p = 0.508, Wilcoxon) 
difference in the level of IL-8 in EBC before [85 (31) pg/l] 
and 5–15 min after smoking [82 (22) pg/l]; those data 
were based on the EBC from 10 smokers, for whom paired 
samples of sufficient volume were available. In those sub-
jects, the ammonium concentration in EBC before and 
5–15 min after smoking was 6.0 (4.0) and 5.6 (2.2)   g/ml, 
respectively, which is not significantly different (p = 
0.554, Wilcoxon). Electrical conductivity before and after 
smoking was 40 (24) and 90 (41)   S/cm, and these values 
are significantly different from each other (p = 0.007) 
( fig. 1 b).
 Correlation analyses did not reveal statistically signif-
icant correlations between the different measurements or 
their changes after smoking, except for a correlation be-
tween conductivity and ammonium after smoking (r S = 
0.72, p = 0.019;  fig. 2 ).
 Chronic Effects of Smoking on EBC 
 EBC was collected in subjects with a smoking history 
of  1 10 PYs (n = 20). In those subjects, the median (IQR in 
parentheses) pH was 7.40 (2.26), while in those with a his-
tory of  ! 10 PYs (n = 9) it was 8.17 (0.68), and in control 
subjects (n = 19) 8.20 (0.40) ( fig. 3 a). There was a signifi-
cant difference between groups (p = 0.001, Kruskal-Wal-
lis). Specifically, smokers with  1 10 PYs showed lower val-
ues than control subjects (p  ! 0.001, Mann-Whitney) or 
smokers with  ! 10 PYs (p = 0.013), whose values did not 
significantly differ (p = 0.731) from those of controls.
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 To further elucidate these differences, we compared 
subjects from different groups selected at random from 
the population of control subjects, patients with stable 
COPD, patients with an exacerbation of COPD, and 
smokers with  1 10 PYs. Each group consisted of 10 sub-
jects. There was a significant difference between these 
four groups (p = 0.014, Kruskal-Wallis), and the Mann-
Whitney U tests confirmed that the median (IQR in pa-
rentheses) pH in control subjects [8.16 (0.22)] was greater 
than in smokers [7.58 (1.17); p = 0.010] and patients with 
stable [7.36 (1.10); p = 0.004] or exacerbated COPD [7.05 
(2.70); p = 0.019] while the last 3 groups did not show any 
significant differences ( fig. 3 b).
 In contrast to pH, IL-8 levels did not differ signifi-
cantly (p = 0.198) between the 4 groups, median (IQR in 
parentheses) values being 67 (80), 85 (31) 66 (9) and 61 
(38) pg/ml in healthy subjects, smokers, and patients with 
stable COPD and COPD during exacerbation, respective-
ly. Moreover, ammonium levels in EBC were 7.2 (1.9)   g/
ml in 10 smokers and 6.0 (4.0)   g/ml in 10 control sub-
jects (p = 0.570). Electrical conductivity of EBC was 58 
(63) and 40 (24)   S/cm, respectively (p = 0.075). Neither 
of these two measurements differed significantly between 
the 2 groups. 
 Discussion 
 The present study showed that acute smoking causes an 
increase in conductivity, correlated with higher amounts 
of ammonium in EBC. Until now, very few data have been 
collected on the acute effects of smoking on human air-
ways. In vitro models revealed that cigarette smoke caused 
an inflammatory response in epithelial cells regarding IL-
6 and IL-8  [22] , while in another model IL-8 production 
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 Fig. 1.  a Time course of pH of EBC in asymptomatic smokers over 
a time period of 35 min after smoking a single cigarette. Each col-
lection of EBC took 10 min, and the time points indicate the start 
of the collection. There were no statistically significant changes 
of pH over time.  b Individual values of electrical conductivity of 
EBC in healthy subjects ( y ) and asymptomatic smokers before 
and after smoking a single cigarette ( { ). While baseline values did 
not differ between groups (p = 0.007), there was a significant in-
crease in conductivity after smoking. 
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 Fig. 2. Relationship between the values of conductivity and am-
monium in the EBC of asymptomatic smokers before ( y ) and
after ( { ) smoking a cigarette. There was a significant correlation 
between the values assessed after smoking (r S = 0.72, p = 0.019). 
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was inhibited  [23] . In the EBC of smokers collected after 
smoking, we observed no significant increase in pH, al-
though a tendency was noted, but we were able to detect 
an increase in conductivity. Conversely, there are data on 
welding fume inhalation, which has been found to in-
crease pH in healthy workers  [24] . So far, the mechanisms 
of pH increase in EBC after inhaling welding fumes have 
been unclear. However, we consider it likely that nonspe-
cific chemical parameters such as pH and conductivity are 
closely related in EBC in most circumstances. Noteworthy 
enough, Do et al.  [25] also found a correlation between pH 
and NH 4 + ; however, this group did not use nose clips as 
recommended  [26] . They further used shorter de-aeration 
periods of only 10 min (we used at least 20 min) and only 
included 5 current smokers. The most important differ-
ence between this and our work is that we measured the 
influence of acute smoking compared with chronic smok-
ers and not only current smokers. 
 Cigarette smoke could affect the pH of EBC by chang-
ing the buffer capacity of the epithelial lining fluid via 
physicochemical mechanisms. For example, the hot 
smoke could raise the local temperature of the lining flu-
id, thereby increasing the dissociation constant of the 
NH 4 + or bicarbonate buffer, the major buffers in EBC. 
According to the van’t Hoff equation, this would imply a 
greater buffer capacity. In view of the difference in heat 
capacities of fluid and gas, such effects are unlikely and 
should be extremely short-lived. It is also unlikely that 
smoking-related differences in breathing patterns, with 
concomitant alterations in CO 2 levels, had an effect. Af-
ter de-aerating the samples with argon prior to measure-
ment, CO 2 was absent as indicated by a blood gas analysis 
(data not shown). Moreover, smoking did not significant-
ly alter the pH of EBC within half an hour. These obser-
vations, as well as the fact that the smokers had refrained 
from smoking for at least 2 h before the assessments, ren-
der it likely that the reduction in pH in asymptomatic 
smokers truly reflected chronic inflammation or damage 
of the airways that were present despite the absence of 
respiratory symptoms and lung function impairment.
 Indeed, it seems reasonable to expect acute inflamma-
tory effects immediately after smoking even in chroni-
cally exposed subjects who  have been smoking  1 10 ciga-
rettes per day, but the concentration of IL-8 in EBC, a 
marker related to inflammatory cellular influx and acti-
vation, did not change after smoking. However, IL-8 lev-
els were also similar in smokers and healthy nonsmokers, 
indicating that this marker was less sensitive to altera-
tions occurring within the airways than pH. The negative 
findings regarding baseline IL-8 are in line with previous 
data showing that epithelial cells cultured from bronchi-
al brush biopsies exhibited a similar constitutive and 
TNF-  -induced IL-8 release in healthy smokers and con-
trol subjects  [27] .
 The decreased pH in asymptomatic smokers matches 
other signs of pulmonary inflammation such as elevated 
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 Fig. 3.  a Individual values of EBC pH obtained with RTube TM in 
healthy control subjects and young asymptomatic smokers with 
diverse smoking histories in terms of PYs. pH values in smokers 
with  1 10 PYs were significantly lower than in control subjects or 
smokers with  ! 10 PYs (p  ! 0.05 each).  b Individual values of EBC 
pH in healthy control subjects, patients with stable COPD ( o in-
dicating COPD ex-smokers) or exacerbated COPD, and asymp-
tomatic smokers with  1 10 PYs (n = 10 per group). pH values in 
control subjects were significantly higher than values of the other 
three groups, including the smokers (p  ! 0.05 each). These three 
groups did not show significant differences in pH values. Hori-
zontal bars indicate median values. 
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numbers of neutrophils and increased amounts of induc-
ible nitric oxide synthase, myeloperoxidase, nitrotyro-
sine and 4-hydroxy-2-nonenal  [28] . The known reduc-
tion of Fe NO in smokers might also indicate inflamma-
tion, possibly resulting from the scavenging of NO by 
reactive oxygen species. Notably, our finding that smok-
ers with a history of  1 10 PYs showed pH values as low as 
patients with COPD is in line with data on the increased 
numbers of inflammatory cells in the small airways of 
smokers with normal spirometry  [29] .
 The pattern observed for electrical conductivity was 
different from that of pH. At baseline, conductivity was 
similar in smokers and nonsmokers, but it showed a 
marked rise after cigarette smoking, suggestive of direct 
chemical reactions to cigarette smoke. This was probably 
not due to increased levels of ammonium ions, which we 
measured as a major compound of EBC. There was, how-
ever, a correlation between these two measurements, at 
least after smoking. Thus, the increase in conductivity 
caused by smoking might still be partially attributed to 
ammonium. In fact, previous observations have suggest-
ed that, at baseline, the ammonium levels correlate very 
well with conductivity in nonlyophilized EBC  [30] . It 
might be speculated that compounds of the inhaled 
smoke were present in the EBC, or that the production of 
endogenous aerosols increased due to minor small air-
way obstruction, thereby increasing EBC conductivity. 
Although our data are not sufficient to address this ques-
tion, they suggest that there is a relationship between con-
ductivity and the acute effects of cigarette smoke and pH, 
which might be relevant for long-term alterations caused 
by cigarette smoke.
 We were able to show that chronic cigarette smoking 
is associated with a lower EBC pH in smokers without 
signs of airway disease, compared to nonsmokers. The 
reduction in pH depends on the duration of smoking, as 
it occurred only in subjects with a smoking history of 
greater than 10 PYs, whereas smokers with fewer PYs (on 
average 3) showed no signs of decreased pH. This finding 
parallels the previous observation that another marker of 
inflammation, i.e. the level of IL-6 in EBC, was depen-
dent on daily cigarette consumption  [12] . Interestingly, 
the reduction in pH was similar to that of patients with 
stable or exacerbated COPD, irrespective of whether they 
were smokers or ex-smokers. Since the pH of EBC to some 
extent mirrors the presence of pulmonary inflammation, 
as described for chronic disorders such as COPD, asthma 
and bronchiectasis  [8, 10, 31] , these findings lend support 
to the assumption of chronic inflammation in asymp-
tomatic smokers.
 Based on these considerations, the change in EBC pH 
in asymptomatic smokers represented an early marker 
of pulmonary inflammation, which could be deter-
mined easily and noninvasively. Future studies might 
assess whether this measurement has additional uses, 
e.g. whether it bears the potential for predicting COPD 
before impairments in lung function might become ap-
parent, or might  support the motivation for giving up 
smoking. 
 It is apparent that the method of EBC analysis is still 
fraught with standardization problems. Different devices 
are used, which may affect sample volume and protein 
content of EBC  [32] . There is no commonly accepted 
measure for adjusting concentrations in EBC which 
would help to achieve comparability between studies. It 
is not known whether the use of the same sampling pe-
riod or a defined ventilated volume would produce more 
comparable results in all instances. Moreover, the storage 
of the samples is a frequently discussed problem. Regard-
ing pH, available data suggest that freezing and thawing 
does not change the pH of the EBC sample  [31] . Whether 
proteins are lost by freezing and thawing has not been 
sufficiently clarified. Despite this limitation, the easy col-
lection of samples, the low costs and new, highly sensitive 
molecular biology tools indicate that EBC analysis is a 
promising method provided the required standardiza-
tion is achieved. 
 In conclusion, the present study demonstrated a re-
duction in the EBC pH in asymptomatic smokers with a 
significant smoking history but no lung function impair-
ment. pH values were similar to those of patients with 
COPD, either with stable disease or exacerbation. It thus 
appeared that the pH in EBC indicated chronic inflam-
mation in the absence of changes in lung function. In as-
ymptomatic smokers, smoking of a single cigarette in-
duced an increase in electrical conductivity, but not in 
pH. As an immediate practical consequence, these find-
ings suggest that subjects should refrain from smoking 
prior to EBC sampling for determinations of conductiv-
ity, and possibly also pH. 
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